In the news | 16th December 2016
2016 was a busy year for the pharmaceutical industry and Scott Weiss, Vice President of Product Strategy, reviews some of the industry’s interesting talking points.
The global pandemic is shining a spotlight on the power of biologics, both vaccines and antibody therapeutics, to prevent serious infections and treat disease.
The licensing and integration of Scitara DLX technology will offer IDBS users plug-and-play connectivity to any instrument or application in regulated and non-regulated laboratories
The collaboration will enable direct integration of IDBS digital solutions with the Genedata Biopharma Platform, accelerating the discovery and development of next-generation biotherapeutics Basel, Switzerland & Boston, MA, USA — January 12, 2021 — Genedata and IDBS, both…